Hemlibra to be publicly funded

We are delighted that the Federal Minister for Health, The Hon. Greg Hunt MP, has announced today that emicizumab (Hemlibra®) will be publicly funded as a treatment for Australians with haemophilia.
 
Hemlibra® is a treatment that can reduce or stop bleeding in people with severe or moderate haemophiia A with and without inhibitors.
 
Gavin Finkelstein, HFA President, said, 'this is great news for our community. We are pleased all governments in Australia have agreed to fund their share of the costs of this treatment product for those in our community who need it'.
 
Minister Hunt said in his press release that regular supply of Hemlibra® is expected to be available by December 2020.

Click here to read Minister Hunt's press release

Latest stories

Welcome to our new website

HFA has a new website! You’ll find all of the same great content and information, but in brand new packaging. Over the past 12 months we’ve been working hard with the team at Heartburst to modernise the HFA website. We have great plans for new features to be added in 2024, so please be patient with us while we’re in the process of developing them.

Read More

Join the HFA community

Sign up for the latest news, events and our free National Haemophilia magazine

Skip to content